Artwork
iconShare
 
Manage episode 493368615 series 3528389
Content provided by Andrew Hattersley and Maggie Shepherd, Andrew Hattersley, and Maggie Shepherd. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Andrew Hattersley and Maggie Shepherd, Andrew Hattersley, and Maggie Shepherd or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.

Richard Oram explains how recent advances have meant we can now delay type 1 diabetes with immunotherapy. To do this we need to be able to identify people at very high risk of developing Type 1 diabetes. Richard thinks genetic analysis could play a part in this identification.

Send us a text

  continue reading

52 episodes